Announced Tue, 9 Jun · 15:11 IST
Marksans Pharma Limited has informed the Exchange that India Ratings and Research has revised the outlook for the Company s bank loan facilities to Positive from Stable
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.1%1-day move
₹236.00
prior close
₹252.99
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.2+0.2—+5.1+6.2+6.7+5.9+4.4+10.8+13.6+18.1——
Up moveDown movePending
AI summary
India Ratings and Research has revised its outlook on Marksans Pharma's bank loan facilities from 'Stable' to 'Positive'. This revision by a recognized credit rating agency signals improving confidence in the company's credit profile and debt-servicing ability. A positive outlook typically precedes a potential upgrade in the actual credit rating if current trends continue.
Likely market impact
This is a positive development for shareholders — it suggests lower borrowing costs ahead and stronger financial health, which could support the stock's valuation.